ADJUVANT CHEMOTHERAPY IN RESECTED NSCLC: TREATMENT FACTORS THAT IMPACT SURVIVAL OUTCOMES

被引：0
|
作者：
Ramsden, K. [1 ]
Laskin, J. [1 ]
Ho, C. [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
76P
引用
收藏
页码：S31 / S32
页数：2
相关论文
共 50 条
  • [41] Adjuvant Chemotherapy With Modified Nab-Paclitaxel and Carboplatin for Completely Resected NSCLC: Survival Analysis of FAST-Nab.
    Saji, H.
    Sakai, H.
    Kimura, H.
    Miyazawa, T.
    Marushima, H.
    Kojima, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S243 - S243
  • [42] SURVIVAL OUTCOMES FOLLOWING ADJUVANT FLUOROPYRIMIDINE-CONTAINING CHEMOTHERAPY FOR RESECTED EARLY STAGE RECTAL ADENOCARCINOMA
    Tay, Rebecca Y.
    Jamnagerwalla, Murtaza
    Steel, Malcolm
    Wong Hui-Li
    McKendrick, Joe J.
    Faragher, Ian
    Kosminder, Suzanne
    Hastie, Ian
    Desai, Jayesh
    Harold, Michael
    Gibbs, Peter
    Wong, Rachel
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 106 - 106
  • [43] Adjuvant targeted therapy for resected NSCLC: to be or not to be?
    Ye, Ting
    Chen, Haiquan
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3297 - S3299
  • [44] ASO Visual Abstract: Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers
    Kristen E. Rhodin
    Annie Liu
    Alex Bartholomew
    Ryan Kramer
    Anika Parameswaran
    Hope Uronis
    John Strickler
    David Hsu
    Michael A. Morse
    Kevin N. Shah
    Garth Herbert
    Sabino Zani
    Daniel P. Nussbaum
    Peter J. Allen
    Michael E. Lidsky
    Annals of Surgical Oncology, 2023, 30 : 4824 - 4825
  • [45] The Impact of Adjuvant Chemotherapy on Survival in Pancreatic Cancer after Neoadjuvant Treatment
    Gruhl, J. D.
    Francis, S.
    Christensen, M. C.
    Nevala-Plagemann, C.
    Lloyd, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E73 - E73
  • [46] Impact of delay in adjuvant chemotherapy on survival in resected gastric cancer: Real world data from India
    Arora, S.
    Sharma, A.
    Pramanik, R.
    Raina, V.
    Deo, S. V. S.
    Kumar, S.
    Shukla, N. K.
    Pal, S.
    Dash, N. R.
    Pathy, S.
    Mohanty, B. K.
    ANNALS OF ONCOLOGY, 2021, 32 : S1054 - S1055
  • [47] Does Delay of Adjuvant Chemotherapy Impact Survival in Patients With Resected Stage II and III Colon Adenocarcinoma?
    Bayraktar, Ulas Darda
    Chen, Emerson
    Bayraktar, Soley
    Sands, Laurence R.
    Marchetti, Floriano
    Montero, Alberto Jose
    Rocha-Lima, Caio Max S.
    CANCER, 2011, 117 (11) : 2364 - 2370
  • [48] Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinoma
    Al Abbas, Amr I.
    Falvello, Virginia
    Zenati, Mazen
    Mani, Ashika
    Hogg, Melissa E.
    Zeh, Herbert J., III
    Singhi, Aatur
    Bahary, Nathan
    Zureikat, Amer H.
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (02) : 322 - 329
  • [49] Adjuvant Chemotherapy for Resected Intrahepatic Cholangiocarcinoma Confers No Survival Advantage.
    Sharib, Jeremy
    Liu, Annie
    McIntyre, Sarah
    Rhodin, Kristen E.
    Kemeny, Nancy E.
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Soares, Kevin C.
    Wei, Alice C.
    Drebin, Jeffrey
    Kingham, T. Peter
    D'Angelica, Michael I.
    Uronis, Hope
    Strickler, John H.
    Morse, Michael A.
    Zani, Sabino
    Allen, Peter J.
    Jarnagin, William R.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S10 - S10
  • [50] Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
    Sharib, Jeremy
    Liu, Annie
    McIntyre, Sarah Margaret Helena
    Rhodin, Kristen Elizabeth
    Kemeny, Nancy E.
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Soares, Kevin
    Wei, Alice Chia-chi
    Drebin, Jeffrey A.
    Kingham, T. Peter
    D'Angelica, Michael Ian
    Uronis, Hope Elizabeth
    Strickler, John H.
    Morse, Michael
    Zani, Sabino
    Allen, Peter J.
    Jarnagin, William R.
    Lidsky, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 560 - 560
12345